IBIO: iBio, Inc. Stock

by  •  • Comments Off on IBIO: iBio, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 8.79
Enterprise Value ($M) 4.14
Book Value ($M) 13.89
Book Value / Share 1.41
Price / Book 0.70
NCAV ($M) 0.48
NCAV / Share 0.05
Price / NCAV 20.03

Profitability (mra)
Return on Invested Capital (ROIC) -1.04
Return on Assets (ROA) -0.38
Return on Equity (ROE) -0.78

Liquidity (mrq)
Quick Ratio 1.76
Current Ratio 1.76

Balance Sheet (mrq) ($M)
Current Assets 8.29
Assets 21.70
Liabilities 7.80
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Opaleye Management Inc. 7.60 15.38
02-14 13G/A ADAR1 Capital Management, LLC 9.99 13.42
01-30 13G/A Crutcher Patrick J 7.00
01-03 13G/A Sabby Management, Llc 0.20 -90.39
11-14 13G Ikarian Capital, LLC 6.60
2024-04-05 13G ADAR1 Partners, LP 9.27
2024-04-01 13G Lynx1 Capital Management LP 9.99

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 94,302 481,195 19.60
2025-04-16 183,467 622,019 29.50
2025-04-15 86,175 325,511 26.47

(click for more detail)

Similar Companies
HOOK – HOOKIPA Pharma Inc. HOTH – Hoth Therapeutics, Inc.
HRTX – Heron Therapeutics, Inc. ICCC – ImmuCell Corporation
IKT – Inhibikase Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io